|
Roflumilast Gets the Go-Ahead for Patients with Asthma-COPD Overlap Syndrome
MD Magazine V. Beloglazov, from the Medical Academy named after S. I. Georgievsky in Russia, and colleagues studied the effects of roflumilast in patients with ACOS and presented the findings in a poster session at the 2015 American College of Allergy, Asthma, and … |
View full post on asthma – Google News